Parasitology: Towards schistosomiasis vaccines

Current status of vaccines for schistosomiasis.

Schistosomiasis, caused by trematode blood flukes of the genus Schistosoma, is recognized as the most important human helminth infection in terms of morbidity and mortality. Infection follows direct contact with freshwater harboring free-swimming larval (cercaria) forms of the parasite. Despite the existence of the highly effective antischistosome drug praziquantel (PZQ), schistosomiasis is spr...

Towards universal influenza vaccines?

Vaccination is the most cost-effective way to reduce the considerable disease burden of seasonal influenza. Although seasonal influenza vaccines are effective, their performance in the elderly and immunocompromised individuals would benefit from improvement. Major problems related to the development and production of pandemic influenza vaccines are response time and production capacity as well ...

Parasitology

e tAninlnrius. Linnoeus, from London, and at mens of not tjie saiue About that once found he ^c^gen3 to Mr. Distant, who kindly time I sen were macrocephalus, Fieber. In informec tQ gnlj out whether lectularius did or f,r' !r,,r in India. I obtained, through the civil and really occ , 8 a T0ry large collection of bugs medical a Tn(]'ia, Burma, Assam, and the Malay from ail par result of the exa...

Integrating parasitology and marine ecology: Seven challenges towards greater synergy

Cysteine Peptidases as Schistosomiasis Vaccines with Inbuilt Adjuvanticity

Schistosomiasis is caused by several worm species of the genus Schistosoma and afflicts up to 600 million people in 74 tropical and sub-tropical countries in the developing world. Present disease control depends on treatment with the only available drug praziquantel. No vaccine exists despite the intense search for molecular candidates and adjuvant formulations over the last three decades. Cyst...